![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Romoli, Simone; Angelotti, Maria Lucia; Antonelli, Giulia; Kumar, Santhosh V. R.; Mulay, Shrikant R.; Desai, Jyaysi; Gomez, Lidia Anguiano; Thomasova, Dana; Eulberg, Dirk; Klussmann, Sven; Melica, Maria Elena; Conte, Carolina; Lombardi, Duccio; Lasagni, Laura; Anders, Hans-Joachim und Romagnani, Paola
(2018):
CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.
In: Kidney International, Bd. 94, Nr. 6: S. 1111-1126
Mulay, Shrikant R.; Eberhard, Jonathan N.; Desai, Jyaysi; Marschner, Julian A.; Kumar, Santhosh V. R.; Weidenbusch, Marc; Grigorescu, Melissa; Lech, Maciej; Eltrich, Nuru; Müller, Lisa; Hans, Wolfgang; Hrabe de Angelis, Martin; Vielhauer, Volker; Hoppe, Bernd; Asplin, John; Burzlaff, Nicolai; Herrmann, Martin; Evan, Andrew und Anders, Hans-Joachim
(2017):
Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.
In: Journal of the American Society of Nephrology, Bd. 28, Nr. 3: S. 761-768
Andersen, Kirstin; Kesper, Marie Sophie; Marschner, Julian A.; Konrad, Lukas; Ryu, Mi; Kumar, Santhosh V. R.; Kulkarni, Onkar P.; Mulay, Shrikant R.; Romoli, Simone; Demleitner, Jana; Schiller, Patrick; Dietrich, Alexander; Müller, Susanna; Gross, Oliver; Ruscheweyh, Hans-Joachim; Huson, Daniel H.; Stecher, Bärbel und Anders, Hans-Joachim
(2017):
Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.
In: Journal of the American Society of Nephrology, Bd. 28, Nr. 1: S. 76-83
Devarapu, Satish Kumar; Kumar, Santhosh V. R.; Rupanagudi, Khader Valli; Kulkarni, Onkar P.; Eulberg, Dirk; Klussmann, Sven und Anders, Hans-Joachim
(2017):
Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis (Reprinted from Clinical Immunology, vol 169, pg 139-147, 2016).
In: Clinical Immunology, Bd. 185: S. 119-127
Devarapu, Satish Kumar; Kumar, Santhosh V. R.; Rupanagudi, Khader Valli; Kulkarni, Onkar P.; Eulberg, Dirk; Klussmann, Sven und Anders, Hans-Joachim
(2016):
Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
In: Clinical Immunology, Bd. 169: S. 139-147
Kumar, Santhosh V. R.; Darisipudi, Murthy N.; Steiger, Stefanie; Devarapu, Satish Kumar; Tato, Maia; Kukarni, Onkar P.; Mulay, Shrikant R.; Thomasova, Dana; Popper, Bastian; Demleitner, Jana; Zuchtriegel, Gabriele; Reichel, Christoph; Cohen, Clemens D.; Lindenmeyer, Maja T.; Liapis, Helen; Moll, Solange; Reid, Emma; Stitt, Alan W.; Schott, Brigitte; Gruner, Sabine; Haap, Wolfgang; Ebeling, Martin; Hartmann, Guido und Anders, Hans-Joachim
(2016):
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.
In: Journal of the American Society of Nephrology, Bd. 27, Nr. 6: S. 1635-1649
Kumar, Santhosh V. R. und Anders, Hans-Joachim
(2016):
Cathepsins are potential therapeutic targets in kidney disease.
In: Kidney international, Bd. 90, Nr. 5: S. 933-935